Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) with Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date7/29/24 → …